Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

AAN honors Mayo Clinic researcher with John Dystel Prize for MS work

The American Academy of Neurology is awarding the 2011 John Dystel Prize for Multiple Sclerosis Research to Brian G. Weinshenker, MD, of the Mayo Clinic in Rochester, Minnesota and a Fellow with the AAN.

1 Apr 2011

Anavex screening volunteers for phase I, first-in-human clinical study in Alzheimer’s

Anavex Life Sciences Corp. today announced screening of the first healthy volunteers for the Phase I clinical study of ANAVEX 2-73, its lead compound for the treatment of Alzheimer’s disease. ANAVEX 2-73 is the first of a new class of wholly-owned, oral, disease-modifying compounds, which act through sigma-1 receptor agonist as well as muscarinic cholinergic effects and up-regulation of Bcl-2.

31 Mar 2011

Adeona reports $3,164,512 net revenue for 2010

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, reported its financial results for the year ended December 31, 2010, as well as updates since the beginning of the 4th quarter.

31 Mar 2011

Basic Yellow 1 dye extends lifespan in healthy nematodes, slows Alzheimer's disease-like pathology in worms

Basic Yellow 1, a dye used in neuroscience laboratories around the world to detect damaged protein in Alzheimer's disease, is a wonder drug for nematode worms. In a study appearing in the March 30, online edition of Nature, the dye, also known as Thioflavin T, (ThT) extended lifespan in healthy nematode worms by more than 50 percent and slowed the disease process in worms bred to mimic aspects of Alzheimer's.

31 Mar 2011

Thirty four new beneficial compounds found in pure maple syrup

University of Rhode Island researcher Navindra Seeram has discovered 34 new beneficial compounds in pure maple syrup and confirmed that 20 compounds discovered last year in preliminary research play a key role in human health.

31 Mar 2011

IAN launches major survey to study elopement, wandering behavior in individuals with ASD

Today, the Interactive Autism Network, with support from leading autism advocacy groups, launches the first major survey to study the experience of wandering and elopement, or escaping, among individuals with autism spectrum disorders.

31 Mar 2011

Amyloid plaques in normal older individuals may be early signs of Alzheimer's

Researchers using two brain-imaging technologies have found that apparently normal older individuals with brain deposits of amyloid beta - the primary constituent of the plaques found in the brains of Alzheimer's disease patients - also had changes in brain structure similar to those seen in Alzheimer's patients.

31 Mar 2011

ADI, Fondation Médéric Alzheimer honor Britain's psychiatry professor with international award

Dr. Sube Banerjee, one of the world's leading experts on Alzheimer's disease is the recipient of an international award for the best evidence-based psychosocial intervention for people with dementia and their caregivers.

30 Mar 2011

New research to examine links between aluminium and Alzheimer's disease

New research is being carried out at Keele university to examine links between aluminium and Alzheimer's disease.

29 Mar 2011

Protein aggregation plays a significant role in cancer

Protein aggregation, generally associated with Alzheimer's and mad cow disease, turns out to play a significant role in cancer. In a paper published in Nature Chemical Biology, Frederic Rousseau and Joost Schymkowitz of VIB, K.U.Leuven and Vrije Universiteit Brussel describe that certain mutations of p53, an important tumor suppressor, cause the protein to misfold in a way that the proteins start to aggregate.

29 Mar 2011

Researchers find patients with Alzheimer's have lower glucose utilization in brain

Researchers at Mount Sinai School of Medicine have found that patients with Alzheimer's disease have lower glucose utilization in the brain than those with normal cognitive function, and that those decreased levels may be detectable approximately 20 years prior to the first symptoms of Alzheimer's disease.

29 Mar 2011

Atypical antipsychotics is a safe mental health medication for nursing home residents

Conventional antipsychotics, antidepressants and benzodiazepines often administered to nursing home residents are no safer than atypical antipsychotics and may carry increased risks, according to an article in CMAJ.

29 Mar 2011

Study: Marijuana use may affect cognitive skills in patients with MS

Any possible pain relief that marijuana has for people with multiple sclerosis may be outweighed by the drug's apparent negative effect on thinking skills, according to research published in the March 29, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

29 Mar 2011

Dementia & Alzheimer’s drug trial with sleep hormone melatonin

A new drug is in the making that could improve the quality of life for people with dementia. Glasgow-based medical research company CPS Research is conducting a clinical trial using a drug containing the sleep hormone melatonin, which it is hoped will reduce the symptoms associated with the illness.

28 Mar 2011

ADDF awards Yuma $249,810 grant for Alzheimer's research

The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $249,810 to Yuma Therapeutics Corporation to develop small molecules to treat Alzheimer's disease.

28 Mar 2011

NMSS grants Adeona's ongoing Trimesta trial with $409,426 to treat MS

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that the ongoing clinical trial of its Trimesta drug candidate has received an additional $409,426 in grant funding from the National Multiple Sclerosis Society.

28 Mar 2011

University of Aberdeen, TPP enter agreement to develop novel future medicines

TPP Global Development Ltd has announced an agreement with the University of Aberdeen to collaborate on the development of novel pre-clinical intellectual property originated within the University.

28 Mar 2011

Geriatrician provides latest Alzheimer drug research developments at International conference

Drugs that can stop or reverse Alzheimer's disease progression are not available yet, but a number of potentially promising clinical trials could hold the key for modifying the treatment of the disease.

28 Mar 2011

Zileuton can help reduce amyloid plaque formation and Alzheimer's development

A drug used to treat asthma has been shown to help reduce the formation of amyloid beta, a peptide in the brain that is implicated in the development of Alzheimer's disease, according to researchers at Temple University's School of Medicine.

28 Mar 2011

Experts to address worldwide impact of Alzheimer's disease at ADI conference

On Sunday March 27 leaders at the 26th Annual Conference of Alzheimer's Disease International will challenge the World Health Organization and countries around the world to take action on the dramatic surge in the global incidence of Alzheimer's disease and dementia.

25 Mar 2011